4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-114787
General Counsel and Secretary sold 1,089 shares at $46.28 ($50,399)
- General Counsel and Secretary acquired 2,113 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…